Zantac And Cancer Diagnosis
Zantac (ranitidine) is a drug used to treat and prevent heartburn, stomach ulcers, and other conditions that cause too much acid to build up in the stomach available both by prescription and over the counter. On April 1, 2020, the FDA announced that it had requested manufacturers of ranitidine drugs from the market due to an ongoing investigation of the presence of a certain carcinogen called NDMA—which may potentially cause cancer, even in small amounts. The type of cancers that have been linked to Zantac are:
- Stomach, Liver, Pancreatic and Intestinal Cancer
- Brain Cancer
- Esophageal, Nasal and Throat Cancer
- Breast, Ovarian and Uterine Cancer
- Kidney and Bladder Cancer
- Prostate and Testicular Cancer
- Thyroid Cancer
If you or someone close to you has been diagnosed with cancer and you feel Zantac may have been a contributing factor, give us a call before it is too late. You may be entitled to a cause of action. You do not pay any attorney fees unless we win or settle on your behalf.
The attorneys at The Spencer Law Firm can help you understand your legal options in these complicated claims. If you or your loved one’s case has merit, we can help you pursue fair and just compensation for the hardships you have suffered due to the actions of a negligent drug manufacturer.
In 2019, a study found that Zantac and its generic equivalent ranitidine contained an unsafe level of a carcinogen called NDMA. The use of the drug has been linked to many types of cancer, including cancer of the stomach, kidneys, bladder and esophagus.
A new study in December 2020 from the American Chemical Society suggests that the presence of NDMA resulted from the degradation of the active chemical contained in Zantac. This means that the amount of NDMA present in ranitidine increases the longer it is kept on the shelves. The significance of this study shows that Zantac may produce high carcinogen concentrations well in excess of the FDA’s acceptable consumption limit of NDMA.
Ongoing study and increasing data suggest a strong correlation between the active ingredient in Zantac and development of cancer in certain users of the drug. Since NDMA exposure is suspected to increase the risk of certain cancers, you should consult with your doctor if you experience certain symptoms such as weight loss, back pain, yellowing of the skin or eyes, itchy skin, or painful urination.
Those who unknowingly ingested this harmful chemical now face significant pain and suffering and costly, ongoing medical treatment. Sadly, many have died. Our attorneys are dedicated to helping victims of negligence. Whether you have suffered cancer from using Zantac or have lost a loved one, we are here to help you pursue fair and just financial compensation for the losses you have suffered.
Get The Legal Help You Need
The Zantac lawsuits have been consolidated into multi-district litigation in the Southern District of Florida. Contact us if you took Zantac or any ranitidine product and have been diagnosed with cancers such as bladder, liver, stomach or pancreatic cancer.